JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (2): 23-27.doi: 10.6040/j.issn.1673-3770.1.2016.07
Previous Articles Next Articles
CHEN Xiaohong
CLC Number:
[1] Machens A, Gimm O, Hinze R, et al. Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties[J]. J Clin Endocrinol Metab, 2001, 86(3):1104-1109. [2] Mulligan L M. RET revisited: expanding the oncogenic portfolio[J]. Nat Rev Cancer, 2014, 14(3):173-186. [3] Wells S A Jr, Asa S L, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6):567-610. [4] 王笑春, 易凡, 支凯林. 甲状腺髓样癌不同手术方式对预后影响(附46例报告)[J]. 临床军医杂志, 2006,34(3):305-306. [5] Romanchishen A F, Lisovsky O V, Vabalayte K V. Choice of the optimal volume of surgery for patients with sporadic medullary thyroid cancer[J]. Inter J Head Neck Surgery, 2011, 2(1):11. [6] Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer[J]. Br J Surgery, 2008, 95(5):586-591. [7] Sippel R S, Muthusamy K, Herbert C. Current management of medullary thyroid cancer[J]. Oncologist, 2008, 13(5):539-547. [8] Kloos R T, Eng C, Evans D B, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association[J]. Thyroid, 2009, 19(6):565-612. [9] Philip F, Jacob J J, Nihal T, et al. Medullary thyroid carcinoma: a 20-year experience from a centre in South India[J]. Anz J Surgery, 2007, 77(3):130-134. [10] Kandil E, Gilson M M, Alabbas H H, et al. Survival Implications of Cervical Lymphadenectomy in Patients with Medullary Thyroid Cancer[J]. Ann Surgical Oncol, 2010, 18(4):1028-1034. [11] Schwartz D L, Vishal R, Stephanie S, et al. Postoperative radiotherapy for advanced medullary thyroid cancer-local disease control in the modern era[J]. Head & Neck, 2008, 30(7):883-888. [12] Call J A, Caudill J S, Mciver B, et al. A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the mayo clinic experience[J]. Rare Tumors, 2013, 5:e37. [13] Cosma M P, Panariello L, Quadro L, et al. A mutation in the RET proto-oncogene in Hirschsprungs disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B[J]. Biochem J, 1996, 314(Pt 2):397-400. [14] Rossella E, Schlumberger M J, Müller S P, et al. Cabozantinib in progressive medullary thyroid cancer[J]. J Clin Oncol Official J Am Society Clin Oncol, 2013, 31(29):3639-3646. |
[1] | LOU Hongfei, WANG Chengshuo. Progress in classification of chronic sinusitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 10-13. |
[2] | LÜ Dan, LI Mingxia, MA Lanzhi, ZHANG Xinyuan, XIAO Hao, CHEN Fei, LIU Jun, LI Zhen. Neurofibromatosis of the head and neck involving the mediastinum: two cases report [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 82-86. |
[3] | SUN Guochen, SUN Yan, ZHANG Hong, WANG Baowei. Clinical characteristics and treatment of differentiated thyroid carcinoma in children. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 25-28. |
[4] | SUN Bin, GUO Bomin, KANG Jie, DENG Xianzhao, WU Bo, FAN Youben. Standardization of the diagnosis and treatment of anaplastic thyroid carcinoma. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 16-20. |
[5] | PAN Yongjie, PANG Wenhui, SUN Guochen, SUN Yan, ZHANG Hong. Expression and clinical significance of Heparanase and D2-40 in pediatric thyroid carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 29-32. |
[6] | XU Shuhang, LI Chunrui, LIU Chao. Optimal management of differentiated thyroid carcinoma in children. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 12-15. |
[7] | XIE Zhaofeng, LIN Honghao. Analysis of clinical risk factors on the postoperative prognosis of chronic rhinosinusitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 90-93. |
[8] | MA Rongfeng, ZHU Fugao, SUN Meihong, FU Tao, ZHANG Xiaoheng, CAO Lin. Analysis on the relevant prognostic factors of sudden deafness and selection of course of treatment. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 69-74. |
[9] | GONG Shanchun, ZHANG Haidong, ZHANG Qingxiang, HE Shuangba, YU Zhenkun. Meticulous operation of thyroid iobectomy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(2): 5-9. |
[10] | HUANG Xiaoming, LIANG Faya, YU Shitong. Surgical treatment of papillary thyroid carcinoma under endoscopy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(2): 13-16. |
[11] | QIU Jie, SUN Yan. Role of tumor marker in the diagnosis and treatment of thyroid carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(2): 28-31. |
[12] | WANG Yu, MA Ben. Ultrasound guided thermoablation does not fit for thyroid carcinoma and follicular neoplasm. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(2): 20-22. |
[13] | LI Yingying, SONG Xicheng. Advances on genetic polymorphism of DNA double-strand break repair genes and thyroid carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(2): 102-105. |
[14] | CHE Juan, ZHAO Hongchun, LI Jinling, WANG Yanfei. The relationship between D-Dimer and nasopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 47-49. |
[15] | XU Zengrui, ZHANG Jianxin, SHI Jihong, CAI Xiaolan. Repair of tracheal defect after resection of thyroid carcinoma with acellular dermal matrix membrane [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 52-54. |
|